Management of Atopic Dermatitis
Springer International Publishing (Verlag)
978-3-031-54512-2 (ISBN)
This new edition builds upon the foundational knowledge covered in the first edition, covering the epidemiology, pathogenesis, and clinical presentation of atopic dermatitis in both pediatric and adult patients. It provides an overview of the mechanism and presentation of atopic dermatitis and focuses on the management methods experienced dermatologists have used to successfully manage atopic dermatitis. The book includes new chapters describing the special considerations for atopic dermatitis in skin of color patients, dedicated chapters on topical and oral prescription management reflected the latest FDA-approved treatments, and also a chapter covering the updated guidelines from the American Academy of Dermatology. A final chapter includes updates on the future of atopic dermatitis treatment.
This book provides physicians with insights into the management of atopic dermatitis, such as alternative treatments for pruritus, psychosocial impact on patients and families,assessing patient compliance, and patient resources.
Lindsay C. Strowd is an Associate Professor and Interim Chair of Dermatology at the Wake Forest University School of Medicine.
Steven R. Feldman is a Professor of Dermatology and Public Health Sciences at the Wake Forest University School of Medicine.
Katie K. Lovell is a research fellow in the Department of Dermatology at the Wake Forest University School of Medicine and M.D. Candidate at East Carolina University Brody School of Medicine.
Introduction.- Atopic Dermatitis: Disease Background and Risk Factors.- Atopic Dermatitis: Pathophysiology.- Clinical Presentation of Atopic Dermatitis.- Special Considerations for Atopic Dermatitis in Skin of Color Patients.- Atopic Dermatitis Disease Complications.- The Psychosocial Impact of Atopic Dermatitis.- Stressors in Atopic Dermatitis.- The Economics Burden of Atopic Dermatitis.- Defining and Measuring the Scope of Atopic Dermatitis.- Topical Prescription Management (including new topical JAK).- Oral Prescription Management (including new oral JAKs).-Introduction.- Atopic Dermatitis: Disease Background and Risk Factors.- Atopic Dermatitis: Pathophysiology.- Clinical Presentation of Atopic Dermatitis.- Special Considerations for Atopic Dermatitis in Skin of Color Patients.- Atopic Dermatitis Disease Complications.- The Psychosocial Impact of Atopic Dermatitis.- Stressors in Atopic Dermatitis.- The Economics Burden of Atopic Dermatitis.- Defining and Measuring the Scope of Atopic Dermatitis.- Topical Prescription Management (including new topical JAK).- Oral Prescription Management (including new oral JAKs).- Systemic Biologic Management (dupilumab and tralokinumab).- Non-Prescription Treatment Options.- Adherence in Atopic Dermatitis.- Atopic Dermatitis: Managing the Itch.- Atopic Dermatitis Disease Education.- Guidelines from American Academy of Dermatology.- The Future of Atopic Dermatitis Treatment (to be updated-some drugs discussed in this chapter are now FDA approved).
| Erscheinungsdatum | 11.05.2024 |
|---|---|
| Reihe/Serie | Advances in Experimental Medicine and Biology |
| Zusatzinfo | X, 248 p. 9 illus., 7 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Dermatologie |
| Studium ► 2. Studienabschnitt (Klinik) ► Pathologie | |
| Studium ► Querschnittsbereiche ► Epidemiologie / Med. Biometrie | |
| Schlagworte | Atopic dermatitis • Atopic dermatitis complications • Clinical trials atopic dermatitis • Compliance atopic dermatitis • Management of atopic dermatitis • OTC products atopic dermatitis • Psychological impact atopic dermatitis • Target molecules atopic dermatitis • Therapeutics atopic dermatitis |
| ISBN-10 | 3-031-54512-5 / 3031545125 |
| ISBN-13 | 978-3-031-54512-2 / 9783031545122 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
